908 Devices Inc. logo

908 Devices Inc.

MASS | NASDAQ
Chart Builder DCF Calculator
$11.07
+$0.19 (+1.75%)
Sep 22, 2026, 1:59 PM ET · Market open

Company Profile

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Key Executives

Name Position
Kevin J. Knopp Co-Founder, Chief Executive Officer, President & Director
Joseph H. Griffith Chief Financial Officer & Treasurer
Barbara Russo Vice President of Corporate Marketing and Communications
Christopher David Brown Co-Founder, Board Advisor & Director
Don Osmer Vice President of Human Resources
John Kenneweg Senior Vice President of Sales and Product Marketing
Julie Cincotti Global Head of Human Resources
Kevin McCallion Senior Vice President of Products and Production
Kola Otitoju Chief Business & Strategy Officer
Mark S. Levine Chief Legal, Administrative Officer & Corporate Secretary

Latest SEC Filings

Date Type Title
Sep 04, 2026 4 Filing
Aug 27, 2026 4 Filing
Aug 24, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 4 Filing
Aug 12, 2026 4 Filing
Aug 11, 2026 10-Q Quarterly Report
View All SEC Filings
908 Devices Inc.
908 Devices Inc. logo
Country United States
IPO Date Dec 17, 2020
Industry Medical - Specialties
Sector Healthcare
Employees 172
CEO Kevin J. Knopp

Contact Details

44 3rd Avenue Burlington, Massachusetts 01803 United States

Stock Details

Ticker Symbol MASS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001555279
CUSIP Number 65443P102
ISIN Number US65443P1021
SIC Code 3829

© 2026 bestshares.com. All rights reserved.